Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.440
-0.040 (-2.70%)
Feb 19, 2026, 9:50 AM EST - Market open
Celularity Market Cap
Celularity has a market cap or net worth of $41.53 million as of February 19, 2026. Its market cap has decreased by -8.57% in one year.
Market Cap
41.53M
Enterprise Value
109.32M
1-Year Change
-8.57%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $41.53M, a decrease of -88.21%. That is a compound annual growth rate of -27.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 42.68M | 35.01% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 40.00M |
| Telomir Pharmaceuticals | 39.54M |
| Aligos Therapeutics | 39.29M |
| Xilio Therapeutics | 38.93M |
| Veru Inc. | 37.91M |
| INmune Bio | 37.75M |
| PDS Biotechnology | 37.29M |
| RenovoRx | 36.28M |